Tringale KR, Wolden SL, Karajannis M, Haque S, et al. Outcomes of intraventricular 131-I-omburtamab and external beam radiotherapy in patients with recurrent medulloblastoma and ependymoma. J Neurooncol 2023 Feb 28. doi: 10.1007/s11060-022-04235.
PMID: 36853490